[1]Pyne NJ,Pyne S.Sphingosine 1-phosphate is a missing link between chronic inflammation and colon cancer[J].Cancer Cell,2013,23(1):5-7.
[2]曹相玫,郭东更,谷雨,等.ZH2在原发性肝癌发展中的作用及临床病理意义[J].现代医药卫生,2012,28(23):3521-3524.
[3]Sasaki M,Ikeda H,Itatsu K,et al.The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma [J].Lab Invest,2008,88(8):873-882.
[4]Ronan JL,Wu W,Crabtree GR.From neural development to cognition:Unexpected roles for chromatin[J].Nat Rev Genet,2013,10:3413-3415.
[5]Dagdemir A,Durif J,Ngollo M,et al.Histone lysine trimethylation or acetylation can be modulated by phytoestrogen,estrogen or anti-HDAC in breast cancer cell lines[J].Epigenomics,2013,5(1):51-63.
[6]Sudo T,Utsunomiya T,Mimori K,et al.Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma[J].Br J Cancer,2005,92(9):1754-1758.
[7]Chen H,Rossier C,Antonarakis SE.Cloning of a human homolog of the Drosophila enhancer of zeste gene(EZH2) that maps to chromosome 21q22.2[J].Genomics,1996,38(1):30-37.
[8]Hillier LW,Fulton RS,Fulton LA,et al.The DNA sequence of human chromosome 7 [J].Nature,2003,424(6945):157-164.
[9]Guo J,Cai J,Yu L,et al.EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vitvo[J].Cancer Sci,2011,102(3):530-539.
[10]Luo M,Li Z,Wang W,et al.Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression[J].Cancer Lett,2013,1:33-36.
[11]Li K,Chen MK,Situ J,et al.Role of co-expression of c-Myc,EZH2 and p27 in prognosis of prostate cancer patients after surgery[J].Chin Med J(Engl),2013,126(1):82-87.
[12]Ren G,Baritaki S,Marathe H,et al.Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer [J].Cancer Res,2012,72(12):3091-3104.
[13]Benard A,Goossens-Beumer IJ,Van Hoesel AQ,et al.Prognostic value of Polycomb proteins EZH2,BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancer[J].PLoS One,2014,22(9):e108265-108267.
[14]Simon JA,Lange CA.Roles of the EZH2 histone methyltransferase in cancer epigenetics[J].Mutat Res,2008,647(1-2):21-29.
[15]Yamaguchi H,Huang MC.Regulation and role of EZH2 in cancer[J].Cancer Res Treat,2014,46(3):209-222.